Updates are available Correction dated 2019-05-22
Click to view Correction: https://doi.org/10.1007/s12028-019-00721-8
-
Authors
Moheet, Asma M.
Livesay, Sarah L.
Abdelhak, Tamer
Bleck, Thomas P.
Human, Theresa
Karanjia, Navaz
Lamer-Rosen, Amanda
Medow, Joshua
Nyquist, Paul A.
Rosengart, Axel
Smith, Wade
Torbey, Michel T.
Chang, Cherylee W. J.
- License Information
-
More Information
Article History
First Online: 24 September 2018
Change Date: 22 May 2019
Change Type: Correction
Change Date: 22 May 2019
Change Type: Correction
Change Type: Correction
Change Details: The authors note that there is a discrepancy between the text of the paper and Table��2 regarding physician subspecialty certification requirements in neurocritical care for Level II centers.
Change Details: The authors note that there is a discrepancy between the text of the paper and Table��2 regarding physician subspecialty certification requirements in neurocritical care for Level II centers.
Change Date: 22 May 2019
Change Details: The authors note that there is a discrepancy between the text of the paper and Table��2 regarding physician subspecialty certification requirements in neurocritical care for Level II centers.
Compliance with Ethical Standards
:
: AMM reports honoraria received from the Medical Speakers Network, serving on a Scientific Advisory Board for Portola Pharmaceuticals, and as an ENLS Instructor. SL reports personal fees from Stryker NV/SPS, Lombardi Hill, and Sarah Livesay LLC. TH reports personal fees from Cheisi and UCB Pharma. JM is a shareholder of iVMD and personal fees from CMTO.
Free to read: This content has been made available to all.
